ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #4,009Hybrid

Cancer Prevention Research

Abbreviation (ISO):CANCER PREV RES
•
Identifier (ISSN):1940-6207(Print)/1940-6215(Online)
•
Publisher:American Association for Cancer Research Inc.
Clarivate IF (2026)
3.4↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Prevention Research

WoS Q2
13464.0220183.8720193.4720203.4920213.320223.320232.920242.620253.42026
Annual Impact Factor Metric
Current (2026):3.4
Scopus SJR & RankScopus Q1
1.129
#4,009

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
120

120 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate3.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
102articles/year
24.43% Gold OA•93.9% Original Research

Aims & Scope

Cancer Prevention Research publishes original studies, reviews, and perspectives in the field of cancer prevention. Its scope includes the molecular and cellular biology of premalignancy and early lesions; genetic and environmental risk factors; risk assessment and reduction; early detection research (cancer screening and diagnosis); and preventive interventions (chemoprevention, immunoprevention, and others) to intercept cancer development at early stages prior to initiation, promotion, or progression. The journal comprises preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

Topics Covered (Recognized by AI)
Medicine96.6%Biology95.5%Internal medicine92.5%Genetics91.8%Cancer82.1%Chemistry66.9%Biochemistry64.2%Pathology55.9%Gene40%Cancer research35.3%Oncology34.9%Endocrinology34.8%Mathematics23.4%Surgery22.1%Organic chemistry21.6%Statistics20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q2
Rank148/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q3
Rank167/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.4
Articles / Year49
Total Citations9
2025
IF2.6
Articles / Year87
Total Citations160
2024
IF2.9
Articles / Year77
Total Citations417
2023
IF3.3
Articles / Year166
Total Citations541
2022
IF3.296
Articles / Year202
Total Citations966

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,009Scopus Q1SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.129

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.01

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,425 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations682
3-Year Documents237
Citable Documents227

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate53.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
Cancer ResearchQ2
OncologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Prevention Research (abbr: CANCER PREV RES, ISSN: 1940-6207) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Association for Cancer Research Inc. in United States since 2008. The periodical holds a Journal Impact Factor (JIF) of 3.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.129 (Q1), an H-index of 120.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 102 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,425 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Monthly
Founding Year
2008
Indexing & Databases
SCIEScopusPubMed
Editorial Address
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1c6efc2e-ae4f-4555-8bea-322e5fa70ecc
Database Updated: 2026-09-28